This finding is notable because STAT1 is a prominent regulator of inflammation in immune and vascular cells during atherosclerosis, and an important therapeutic target for cardiovascular disease [144], the main cause of death of HGPS patients. Here, STAT1 is linked to Hutchinson-Gilford progeria syndrome.